JP2024534567A5 - - Google Patents
Info
- Publication number
- JP2024534567A5 JP2024534567A5 JP2024518351A JP2024518351A JP2024534567A5 JP 2024534567 A5 JP2024534567 A5 JP 2024534567A5 JP 2024518351 A JP2024518351 A JP 2024518351A JP 2024518351 A JP2024518351 A JP 2024518351A JP 2024534567 A5 JP2024534567 A5 JP 2024534567A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- piperidyl
- pyridine
- pyridyl
- piperazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021120406 | 2021-09-24 | ||
| CNPCT/CN2021/120406 | 2021-09-24 | ||
| CN2022089033 | 2022-04-25 | ||
| CNPCT/CN2022/089033 | 2022-04-25 | ||
| PCT/EP2022/076306 WO2023046806A1 (en) | 2021-09-24 | 2022-09-22 | Pyrazolo[3,4-b]pyridine compounds for the treatment of autoimmune disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534567A JP2024534567A (ja) | 2024-09-20 |
| JP2024534567A5 true JP2024534567A5 (enExample) | 2025-09-26 |
Family
ID=83688579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024518351A Pending JP2024534567A (ja) | 2021-09-24 | 2022-09-22 | 自己免疫疾患の処置のためのピラゾロ［３，４－ｂ］ピリジン化合物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20240360126A1 (enExample) |
| EP (1) | EP4405051A1 (enExample) |
| JP (1) | JP2024534567A (enExample) |
| KR (1) | KR20240065092A (enExample) |
| CN (1) | CN118076604A (enExample) |
| AR (1) | AR127126A1 (enExample) |
| AU (1) | AU2022351495A1 (enExample) |
| CA (1) | CA3228485A1 (enExample) |
| CL (1) | CL2024000791A1 (enExample) |
| CO (1) | CO2024003401A2 (enExample) |
| CR (1) | CR20240134A (enExample) |
| IL (1) | IL310443A (enExample) |
| MX (1) | MX2024003444A (enExample) |
| PE (2) | PE20240815A1 (enExample) |
| TW (1) | TW202328129A (enExample) |
| WO (1) | WO2023046806A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024222889A1 (zh) * | 2023-04-28 | 2024-10-31 | 成都思倍博医药科技有限公司 | 含氧代吡啶并脂肪环或脂杂环结构的化合物及其医药用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3080124A1 (en) * | 2013-12-13 | 2016-10-19 | Takeda Pharmaceutical Company Limited | Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors |
| CR20190119A (es) | 2016-09-09 | 2019-06-03 | Novartis Ag | Compuestos y composiciones como inhibidores de los receptores endosomales tipo peaje |
| JP7407740B2 (ja) | 2018-05-18 | 2024-01-04 | ノバルティス アーゲー | Ｔｌｒ７／ｔｌｒ８阻害剤の結晶形態 |
| WO2022013136A1 (en) * | 2020-07-14 | 2022-01-20 | F. Hoffmann-La Roche Ag | Hydroisoquinoline or hydronaphthyridine compounds for the treatment of autoimmune disease |
-
2022
- 2022-09-22 AU AU2022351495A patent/AU2022351495A1/en active Pending
- 2022-09-22 CN CN202280063841.XA patent/CN118076604A/zh active Pending
- 2022-09-22 CA CA3228485A patent/CA3228485A1/en active Pending
- 2022-09-22 IL IL310443A patent/IL310443A/en unknown
- 2022-09-22 MX MX2024003444A patent/MX2024003444A/es unknown
- 2022-09-22 AR ARP220102558A patent/AR127126A1/es unknown
- 2022-09-22 JP JP2024518351A patent/JP2024534567A/ja active Pending
- 2022-09-22 PE PE2024000482A patent/PE20240815A1/es unknown
- 2022-09-22 EP EP22786353.7A patent/EP4405051A1/en active Pending
- 2022-09-22 KR KR1020247009335A patent/KR20240065092A/ko active Pending
- 2022-09-22 WO PCT/EP2022/076306 patent/WO2023046806A1/en not_active Ceased
- 2022-09-22 PE PE2024003046A patent/PE20250401A1/es unknown
- 2022-09-22 CR CR20240134A patent/CR20240134A/es unknown
- 2022-09-23 TW TW111136043A patent/TW202328129A/zh unknown
-
2024
- 2024-03-15 US US18/606,123 patent/US20240360126A1/en active Pending
- 2024-03-18 CL CL2024000791A patent/CL2024000791A1/es unknown
- 2024-03-19 CO CONC2024/0003401A patent/CO2024003401A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2023266254B2 (en) | Bifunctional compounds for degrading btk via ubiquitin proteosome pathway | |
| JP7644139B2 (ja) | インダゾール系化合物及び関連使用方法 | |
| CN116368140A (zh) | 杂环glp-1激动剂 | |
| RU2009148673A (ru) | Производные пиразинона и их применение для лечения легочных заболеваний | |
| RU2018123825A (ru) | Соединения и способы для модуляции киназ, и показания для этого | |
| JP2012503018A5 (enExample) | ||
| CA3139019A1 (en) | Amino quinazoline derivatives as p2x3 inhibitors | |
| AU2018390610A1 (en) | Amino indole compounds useful as TLR inhibitors | |
| JP2023539663A (ja) | 急速進行性線維肉腫タンパク質分解化合物及び関連する使用方法 | |
| JP2015510938A5 (enExample) | ||
| JP2012525395A5 (enExample) | ||
| KR20030016283A (ko) | 뉴로키닌 수용체 길항제로서의1,3,8-트리아자-스피로[4.5]데칸-4-온 유도체 | |
| JP2011515462A5 (enExample) | ||
| US10526323B2 (en) | Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | |
| RU2006100190A (ru) | Производные хинолиламида в качестве антагонистов ccr-5 | |
| AU2021242143B2 (en) | Aminopyrimidine derivatives and their use as Aryl hydrocarbon receptor modulators | |
| CN102482256B (zh) | N-取代的环状氨基衍生物 | |
| CA3184990A1 (en) | Pyridazinyl amino derivatives as alk5 inhibitors | |
| CN114907338B (zh) | 含氮多环稠环类化合物，其药物组合物、制备方法和用途 | |
| JP2022527588A5 (enExample) | ||
| JPWO2019216294A5 (enExample) | ||
| JP2025513019A5 (enExample) | ||
| JP2024534567A5 (enExample) | ||
| JP2025509895A (ja) | Ｔｅａドメインファミリーメンバーの小分子阻害薬 | |
| JP2023510971A (ja) | 新規複素環式化合物 |